|
⚲
|
| Keyboard |
| Matthew Price | |
|---|---|
| Firm | |
| Address | 201 Spear Street Suite 1100 San Francisco, CA 94105 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Lizton Financial Corp | 021-590217 | Executive Officer | 25.0 M of 25.0 M |
||
| Crescendoai Inc | 021-526952 | Executive Officer | 31.5 M of 31.5 M |
||
| Crescendoai Inc | 021-526523 | Executive Officer | of 15.0 M |
||
| Phosplatin Therapeutics Inc | 021-425067 | Director | 37.3 M of 37.3 M |
||
| WV Ventures LLC | 021-422863 | Executive Officer | 0.2 M of 0.3 M |
||
| L2LP EIG LLC | 021-373859 | Executive Officer | 2.7 M of 9.0 M |
||
| Phosplatin Therapeutics LLC | 021-373259 | Executive Officer | 18.4 M of 18.4 M |
||
| WVV Thomasville Holdings LLC | 021-349351 | Executive Officer | 2.5 M of 2.5 M |
||
| Phosplatin Therapeutics LLC | 021-325409 | Executive Officer | 16.6 M of 16.6 M |
||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Procter & Gamble Co PG
Common Stock
|
2019-05-01 | Option exercise | 19,401 | $63.05 | 1,223,233 |
|
Procter & Gamble Co PG
Common Stock
|
2019-05-01 | Sell | 19,401 | $106.03 | 2,057,088 |
|
Procter & Gamble Co PG
Stock Option (Right to Buy) · derivative
|
2019-05-01 | Option exercise | 19,401 | $0.00 | |
|
Procter & Gamble Co PG
Stock Option (Right to Buy) · derivative
|
2019-02-28 | Grant | 43,298 | $0.00 | |
|
Procter & Gamble Co PG
Common Stock
|
2019-02-28 | Grant | 6,195 | $0.00 | |
|
Procter & Gamble Co PG
Common Stock
|
2019-02-15 | Sell | 20,000 | $99.00 | 1,980,000 |
|
Procter & Gamble Co PG
Restricted Stock Units · derivative
|
2019-02-15 | Grant | 22.54 | $0.00 | |
|
Procter & Gamble Co PG
Stock Option (Right to Buy) · derivative
|
2019-02-15 | Option exercise | 20,000 | $0.00 | |
|
Procter & Gamble Co PG
Common Stock
|
2019-02-15 | Option exercise | 20,000 | $63.05 | 1,261,000 |
|
Procter & Gamble Co PG
Restricted Stock Units · derivative
|
2018-11-15 | Grant | 23.66 | $0.00 | |
|
Procter & Gamble Co PG
Common Stock
|
2018-11-13 | Option exercise | 32,324 | $63.28 | 2,045,463 |
|
Procter & Gamble Co PG
Stock Option (Right to Buy) · derivative
|
2018-11-13 | Option exercise | 32,324 | $0.00 | |
|
Procter & Gamble Co PG
Common Stock
|
2018-11-13 | Sell | 32,324 | $91.88 | 2,969,929 |
|
Procter & Gamble Co PG
Common Stock
|
2018-11-02 | Sell | 3,081 | $89.89 | 276,951 |
|
Procter & Gamble Co PG
Common Stock
|
2018-08-21 | Grant | 7,183 | $0.00 | |
|
Procter & Gamble Co PG
Restricted Stock Units · derivative
|
2018-08-15 | Grant | 18.59 | $0.00 | |
|
Procter & Gamble Co PG
Common Stock
|
2018-08-07 | Option exercise | 11,626 | $48.17 | 560,024 |
|
Procter & Gamble Co PG
Stock Option (Right to Buy) · derivative
|
2018-08-07 | Option exercise | 11,626 | $0.00 | |
|
Procter & Gamble Co PG
Common Stock
|
2018-08-07 | Sell | 11,626 | $82.00 | 953,332 |
|
Procter & Gamble Co PG
Restricted Stock Units · derivative
|
2018-08-02 | Grant | 945 | $0.00 | |
| showing 20 of 57 most recent transactions | |||||